ALG vs REGN
Alamo Group Inc (ALG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Alamo Group Inc (ALG) is a farm & heavy construction machinery company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ALG revenue for 2024-12-31 was $1.63B. Net income was $115.9M. Revenue was down 3.6% from 2023-12-31 to 2024-12-31. ALG currently screens at market cap $2.72B and trailing P/E 23.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ALG currently screens at market cap $2.72B and trailing P/E 23.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ALG and REGN stock pages for the full models.
Not investment advice.